The ASCO Post Podcast

Addition of Durvalumab to Etoposide Plus Platinum Chemotherapy for Extensive-Stage SCLC


Listen Later

This week, we’ll review an interim analysis of the CASPIAN trial, which evaluated the addition of durvalumab to etoposide plus platinum chemotherapy for extensive-stage small cell lung cancer. Then, we’ll talk about two recently issued guidelines on screening for colorectal cancer. Lastly, we’ll summarize some recent FDA approvals and announcements.

Coverage of stories discussed this week on ascopost.com:

CASPIAN Trial: Addition of Durvalumab to Platinum/Etoposide for First-Line Treatment of Extensive-Stage SCLC

Colorectal Cancer Screening With Fecal Immunochemical Testing, Sigmoidoscopy, or Colonoscopy for Patients Aged 50 to 79 Years Old

American College of Physicians Issues Guidance on Colorectal Cancer Screening for Average-Risk, Asymptomatic Adults Aged 50 to 75 Years

FDA Approves Pegfilgrastim Biosimilar

FDA Approves Niraparib for Patients With Homologous Recombination Deficiency–Positive Advanced Ovarian Cancer

FDA Approves Daratumumab Combination for Transplant-Eligible Patients With Multiple Myeloma

Stephen Hahn, MD, to Be Nominated FDA Commissioner

...more
View all episodesView all episodes
Download on the App Store

The ASCO Post PodcastBy BroadcastMed

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

15 ratings


More shows like The ASCO Post Podcast

View all
Research To Practice | Oncology Videos by Dr Neil Love

Research To Practice | Oncology Videos

116 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

58 Listeners